Meropenem Dosage Strategy Based on PPK Model

PHASE4CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Lower Respiratory Tract Infection
Interventions
DRUG

Routine meropenem therapy

Participants in control group will accept meropenem therapy with regimen routinely decided by attending physician

DRUG

Meropenem therapy based on a PPK and PD model

Participants in study group will accept meropenem therapy based on a software developed from a PPK and PD model

Trial Locations (1)

100191

Peking University Third Hospita, Haidian District

All Listed Sponsors
lead

Qingtao Zhou

OTHER

NCT01944319 - Meropenem Dosage Strategy Based on PPK Model | Biotech Hunter | Biotech Hunter